adverse outcome – Page 20 – Communicable Diseases Research

Encephalopathy at admission predicts adverse outcomes in patients with SARS‐CoV‐2 infection

Observational Study

Published on 2021-06-162022-10-04
Journal: CNS Neuroscience & Therapeutics [Category] MERS, 임상,

Association of Frailty with Adverse Outcomes in Patients with Suspected COVID-19 Infection

Article

Published on 2021-06-022022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study

영국의 6·900만 인구의 체질량 지수와 COVID-19 심각도 사이의 연관성: 전향적, 지역사회 기반, 코호트 연구

Articles

Published on 2021-06-012022-09-12
Journal: The lancet. Diabetes & endocrinology [Category] Fulltext, MERS, 진단,

[키워드] adjusted adjusted hazard ratio Admission adverse outcome adverse outcomes age association available data behavioural black black people BMI body-mass cardiovascular disease Characteristics cohort study Comorbidities conditions COVID-19 COVID-19 severity Cox proportional hazard models database death demographic characteristics diabetes died Diseases eligible England Ethnicity Factors finding for inclusion funding Health hospital Hospital admission hypertension ICU ICU admission increase in individual Infection infection with SARS-CoV-2 intensive care intensive care unit Interaction linear morbidities nadir NIHR notable obesity office Older Oxford Patient positive Positive test Public Health England QResearch recorded Registered Relative risk risk risk factor SARS-CoV-2 SARS-CoV-2 test severe COVID-19 significant interaction Statistics type 2 diabetes White people younger people
[DOI] 10.1016/S2213-8587(21)00089-9 PMC 바로가기 [Article Type] Articles

SARS-CoV-2 infection in patients with autoimmune hepatitis

Research Article

Published on 2021-06-012022-10-30
Journal: Journal of hepatology [Category] COVID-19, MERS, SARS,

[키워드] Abstract acute respiratory syndrome Admission adverse outcome aetiology age Analysis Autoimmune hepatitis baseline cause chronic liver disease cirrhosis CLD Cohort cohort of patient collected coronavirus coronavirus disease Course COVID-19 COVID-19 in patient death demonstrated Factor form globe Hospitalization ICU admission immune system Immunosuppression immunosuppressive Immunosuppressive treatment increased risk Infection Inflammatory intensive care International Laboratory Liver disease liver diseases medication no difference Odds ratio outcome Patient Propensity score PSM reported Result risk risk factor SARS-CoV-2 SARS-COV-2 infection severity suppress the disease
[DOI] 10.1016/j.jhep.2021.01.021 PMC 바로가기 [Article Type] Research Article

Safety of ACE-I and ARB medications in COVID-19: A retrospective cohort study of inpatients and outpatients in California

Research Article

Published on 2021-06-012022-10-30
Journal: Journal of Clinical and Translational Science [Category] COVID-19,

[키워드] 95% CI 95% confidence interval ACE inhibitors (ACE-I) ACE2 acute respiratory syndrome addressed Admission adverse effect adverse outcome age angiotensin II receptor blockers (ARB) ARB association blocker Care Chest computed tomography coronavirus coronavirus disease COVID-19 COVID-19 patient death diagnosed diagnosing entry receptor enzyme follow-up time Hospitalization host cell hypertension increased risk inhibitor Inpatient intensive care lower risk medication medications Odds ratio outcome outcomes Outpatient outpatients past medical history Patient performed polymerase chain recent receptor renin-angiotensin-aldosterone system (RAAS) retrospective cohort study reverse transcription RT-PCR Safety SARS-CoV-2 Stanford translational science
[DOI] 10.1017/cts.2020.489 PMC 바로가기 [Article Type] Research Article

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients

SARS-CoV-2와 인플루엔자 바이러스 감염 환자 간의 전사 서명 차이

Observational Study

Published on 2021-05-312022-09-11
Journal: Frontiers in Immunology [Category] SARS, 유전자 메커니즘, 임상,

[키워드] adverse outcome adverse outcomes B cell blood cell Blood cells Cell cell cycle Complete Complication COVID-19 COVID-19 pathogenesis COVID-19 severity degranulation develop difference distress dramatic increase dysregulated dysregulation dysregulation of T cells Evidence feature gene expression pattern group healthy host response IFN immune profiling immune signature Immunoglobulin Increasing individuals individuals with COVID-19 infected individuals infected with SARS-CoV-2 Influenza influenza viruses involved life-threatening metabolism Neutrophils NK cells over-expression Patient provided reason reduction respiratory distress responses RNA-sequencing SARS-CoV-2 SARS-COV-2 infection severity signature Symptom T cells Toxicity transcriptomic transcriptomic profile transcriptomic profiles website whole blood transcriptome
[DOI] 10.3389/fimmu.2021.666163 PMC 바로가기 [Article Type] Observational Study

Older adults report cancellation or avoidance of medical care during the COVID-19 pandemic: results from the Longitudinal Aging Study Amsterdam

Research Paper

Published on 2021-05-282022-10-31
Journal: European Geriatric Medicine [Category] COVID-19, MERS, SARS,

[키워드] Adults adverse outcome age aging Anxiety association avoidance Care Characteristics chronic conditions cohort study consequence COVID-19 COVID-19 pandemic COVID-19 situation Delay Depression female finding frailty Health Healthcare professional Healthcare use hospital Impact information initiated investigated lockdown loneliness longitudinal message morbidity Multimorbidity Netherlands Older older adult Older adults outcome pandemic primary care quarantine question questionnaire reported Research respondent Result routine care Sex socio-demographic Symptom were assessed were used
[DOI] 10.1007/s41999-021-00514-3 PMC 바로가기 [Article Type] Research Paper

The Association between Influenza Vaccination and COVID-19 and Its Outcomes: A Systematic Review and Meta-Analysis of Observational Studies

Review

Published on 2021-05-202022-10-28
Journal: Vaccines [Category] COVID-19,

Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial

중증 코로나바이러스 질환 2019(COVID-19)로 입원한 성인의 항체 반응 및 임상 결과: LOTUS China 임상시험의 사후 분석

Article

Published on 2021-05-182022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, 치료법,

[키워드] 95% CI 95% confidence interval adjusted adverse outcome analyzed antibody Antibody titers Antigen Chain Reaction Characteristics China clinical Clinical improvement Clinical outcome clinical outcomes collected coronavirus disease Coronavirus disease 2019 correlated correlation COVID-19 COVID-19 patients death determined by ELISA enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay humoral Humoral response IgG IgG antibodies IgG antibody IgG titers IgM immunoglobulin M less linear mixed model LOTUS China microneutralization Microneutralization assay NAb NAbs Neutralizing Neutralizing antibodies neutralizing antibody nonsurvivor nonsurvivors nucleocapsid Patient plasma plasma sample polymerase chain polymerase chain reaction Protein random effect RBD reached Real-Time Reverse Transcription Polymerase Chain Reaction Receptor-binding domain response reverse transcription reverse transcription polymerase chain reaction RT-PCR severe coronavirus disease severe COVID-19 severe COVID-19 patient slope Spike protein statistical survivor symptoms onset the receptor-binding domain throat swab throat swabs Trial Viral viral clearance Viral load was determined were measured
[DOI] 10.1093/cid/ciaa1247 PMC 바로가기 [Article Type] Article

Burnout Impact of COVID-19 Pandemic on Health-Care Professionals at Assiut University Hospitals, 2020

Article

Published on 2021-05-182022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, SARS,